Pictet Asset Management Holding SA lowered its stake in Ventas, Inc. (NYSE:VTR - Free Report) by 68.8% in the 4th quarter, according to its most recent filing with the SEC. The fund owned 207,414 shares of the real estate investment trust's stock after selling 457,119 shares during the period. Pictet Asset Management Holding SA's holdings in Ventas were worth $16,050,000 as of its most recent SEC filing.
Other hedge funds also recently made changes to their positions in the company. Vanguard Group Inc. boosted its holdings in shares of Ventas by 3.2% in the 4th quarter. Vanguard Group Inc. now owns 75,948,003 shares of the real estate investment trust's stock valued at $5,876,856,000 after buying an additional 2,349,176 shares during the period. UBS Group AG increased its stake in shares of Ventas by 142.4% in the third quarter. UBS Group AG now owns 3,507,841 shares of the real estate investment trust's stock valued at $245,514,000 after purchasing an additional 2,060,770 shares during the period. Lasalle Investment Management Securities LLC raised its stake in Ventas by 1,135.1% during the 3rd quarter. Lasalle Investment Management Securities LLC now owns 1,552,880 shares of the real estate investment trust's stock valued at $108,686,000 after acquiring an additional 1,427,151 shares in the last quarter. Sumitomo Mitsui Trust Group Inc. raised its stake in shares of Ventas by 74.2% during the third quarter. Sumitomo Mitsui Trust Group Inc. now owns 2,586,405 shares of the real estate investment trust's stock valued at $181,022,000 after purchasing an additional 1,101,948 shares in the last quarter. Finally, Invesco Ltd. raised its position in shares of Ventas by 21.5% during the 3rd quarter. Invesco Ltd. now owns 5,847,604 shares of the real estate investment trust's stock worth $409,274,000 after buying an additional 1,034,634 shares in the last quarter. Institutional investors and hedge funds own 94.18% of the company's stock.
Insider Buying and Selling
In related news, CEO Debra A. Cafaro sold 10,322 shares of the company's stock in a transaction on Monday, February 2nd. The stock was sold at an average price of $77.66, for a total value of $801,606.52. Following the completion of the transaction, the chief executive officer directly owned 1,114,034 shares in the company, valued at approximately $86,515,880.44. This represents a 0.92% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, EVP Carey S. Roberts sold 35,532 shares of the stock in a transaction on Wednesday, February 11th. The shares were sold at an average price of $85.00, for a total transaction of $3,020,220.00. Following the completion of the transaction, the executive vice president owned 72,755 shares of the company's stock, valued at approximately $6,184,175. This represents a 32.81% decrease in their position. The SEC filing for this sale provides additional information. Insiders own 0.53% of the company's stock.
Ventas Stock Up 0.3%
VTR stock opened at $88.11 on Friday. The stock has a market capitalization of $42.83 billion, a price-to-earnings ratio of 160.20, a price-to-earnings-growth ratio of 2.16 and a beta of 0.74. The company has a 50-day moving average of $84.79 and a two-hundred day moving average of $80.03. The company has a debt-to-equity ratio of 0.95, a current ratio of 0.25 and a quick ratio of 0.67. Ventas, Inc. has a 52-week low of $61.76 and a 52-week high of $88.41.
Ventas (NYSE:VTR - Get Free Report) last issued its quarterly earnings results on Monday, April 27th. The real estate investment trust reported $0.11 EPS for the quarter, missing the consensus estimate of $0.12 by ($0.01). Ventas had a return on equity of 2.09% and a net margin of 4.25%.The business had revenue of $1.65 billion during the quarter, compared to the consensus estimate of $1.59 billion. During the same period in the prior year, the firm earned $0.84 earnings per share. The business's quarterly revenue was up 22.0% on a year-over-year basis. Ventas has set its FY 2026 guidance at 3.820-3.890 EPS. As a group, equities research analysts anticipate that Ventas, Inc. will post 3.85 EPS for the current year.
Ventas Increases Dividend
The company also recently declared a quarterly dividend, which was paid on Thursday, April 16th. Investors of record on Tuesday, March 31st were paid a dividend of $0.52 per share. This is a positive change from Ventas's previous quarterly dividend of $0.48. This represents a $2.08 annualized dividend and a yield of 2.4%. The ex-dividend date was Tuesday, March 31st. Ventas's dividend payout ratio is presently 378.18%.
Wall Street Analysts Forecast Growth
A number of analysts have recently commented on VTR shares. Royal Bank Of Canada boosted their price objective on Ventas from $83.00 to $91.00 and gave the stock an "outperform" rating in a research note on Tuesday, February 10th. Mizuho upped their price objective on shares of Ventas from $87.00 to $94.00 and gave the company an "outperform" rating in a research note on Wednesday, March 4th. KeyCorp raised their target price on Ventas from $85.00 to $90.00 and gave the stock an "overweight" rating in a research report on Tuesday, February 10th. UBS Group restated a "neutral" rating and set a $85.00 price target on shares of Ventas in a report on Monday, February 9th. Finally, Wells Fargo & Company lifted their price objective on Ventas from $88.00 to $93.00 and gave the company an "overweight" rating in a research report on Thursday, March 26th. Thirteen analysts have rated the stock with a Buy rating and three have given a Hold rating to the company. Based on data from MarketBeat.com, Ventas presently has an average rating of "Moderate Buy" and an average target price of $91.73.
View Our Latest Stock Analysis on Ventas
About Ventas
(
Free Report)
Ventas, Inc NYSE: VTR is a real estate investment trust (REIT) that specializes in healthcare-related real estate. The company acquires, owns and manages a diversified portfolio of properties serving the healthcare continuum, including senior housing communities, skilled nursing facilities, medical office buildings, life science and research centers, and other properties leased to healthcare providers and operators. Ventas generates revenue through long-term leases, property management and selective development activities focused on meeting the real estate needs of the healthcare sector.
Ventas' business model combines property ownership with active asset management and capital markets activity.
Featured Articles
Want to see what other hedge funds are holding VTR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Ventas, Inc. (NYSE:VTR - Free Report).
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Ventas, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Ventas wasn't on the list.
While Ventas currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.
Get This Free Report
